v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net loss $ (22,690) $ (40,859)
Net loss from discontinuing operations 6,883 22,284
Reconciliation of net loss to net cash used in operating activities, continuing operations:    
Stock-based compensation 1,186 1,003
Amortization of operating lease right-of-use assets 321 504
Depreciation and amortization expense 522 550
Change in fair value of share-settlement obligation derivative 250
Change in fair value of financial instruments (210)
Accretion of debt discount 173
Loss on conversion of debt 2,518
Other (1) (14)
Changes in operating assets and liabilities, net of impacts of business combination:    
Trade accounts and other receivables 111 (77)
Inventory 422 (60)
Prepaid expense and other assets 321 (165)
Accounts payable (85) (1,146)
Obligations under operating leases (265) (499)
Accrued expenses and other liabilities 387 (740)
Net cash used in operating activities, continuing operations (12,888) (16,488)
Net cash used in operating activities, discontinuing operations (793) (505)
Net cash used in operating activities (13,681) (16,993)
Cash Flows from Investing Activities:    
Purchase of equipment (617) (535)
Proceeds from patent held for sale and equipment sales 50
Cash acquired from acquisition 30,163
Net cash (used in) provided by investing activities, continuing operations (617) 29,678
Net cash provided by (used in) investing activities, discontinuing operations 3,880 (59)
Net cash provided by investing activities 3,263 29,619
Cash Flows from Financing Activities:    
Issuance of common stock, net of issuance costs (188) 41
Issuance of Series C Convertible Preferred Stock, net of issuance costs 1,786
2020 Convertible Note proceeds, net of issuance costs 5,022
Principal payments on long-term debt (82)
Proceeds from lease financing 266 492
Principal payments on obligations under financing leases (191) (37)
Net cash (used in) provided by financing activities, continuing operations (113) 7,222
Net cash used in financing activities, discontinuing operations (36) (32)
Net cash (used in) provided by financing activities (149) 7,190
Net (decrease) increase in cash and cash equivalents (10,567) 19,816
Cash and cash equivalents, beginning of year 20,608 792
Cash and cash equivalents, end of year 10,041 20,608
Supplemental disclosure of cash flow information:    
Cash paid for interest 34 8
Cash paid for income taxes 8
Non-cash investing activities:    
Fair value of non-cash merger consideration 59,920
Right-of-use assets obtained in exchange for new operating lease liabilities 1,189 83
Non-cash financing activities:    
Conversion of Convertible Preferred Stock to Common Stock upon Merger 30,793
Conversion of 2020 Convertible Notes and accrued interest to Common Stock upon Merger 16,190
Reclass warrant liability to equity upon Merger $ 421

Source